Citi Appointed as Depositary Bank for Centessa Pharmaceuticals plc’s ADR Programme
07 June 2021 - 6:00PM
Business Wire
Citi, acting through Citibank N.A., has been appointed by
Centessa Pharmaceuticals plc (“Centessa”), a next-generation
biopharmaceutical company, to act as depositary bank for its
American Depositary Receipt (“ADR”) programme.
Centessa’s American Depositary Shares (“ADSs”) trade on the
Nasdaq Global Market under the symbol “CNTA”. Each ADS represents
one ordinary share of the company.
Commenting on the appointment, Dirk Jones, Global Head of Issuer
Services, at Citi said: “We look forward to supporting Centessa’s
ADR programme and expanding the company’s investor outreach through
the expertise of our Investor Relations Advisory team and the
breadth of our global equity distribution network.”
For more information on Citi’s Depositary Receipt Services,
please visit www.citi.com/dr
About Centessa Centessa Pharmaceuticals plc is a
next-generation biopharmaceutical company that aims to reshape the
traditional drug development process. The company applies an
asset-centric R&D model at scale to advance a portfolio of
programs led by industry-leading teams. Each program is developed
by one of ten Centessa subsidiaries and supported by centralized
infrastructure and the Centessa management team.
Additional information may be found at www.centessa.com
About Citi Citi, the leading global bank, has
approximately 200 million customer accounts and does business in
more than 160 countries and jurisdictions. Citi provides consumers,
corporations, governments and institutions with a broad range of
financial products and services, including consumer banking and
credit, corporate and investment banking, securities brokerage,
transaction services, and wealth management.
Additional information may be found at www.citigroup.com |
Twitter: @Citi | YouTube: www.youtube.com/citi | Blog:
http://blog.citigroup.com | Facebook: www.facebook.com/citi |
LinkedIn: www.linkedin.com/company/citi
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210607005037/en/
Citi Media Contacts: Shani Halstead +44 (0) 20 7508 2352
shani.halstead@citi.com Centessa Investor Contact: Jennifer
Porcelli, Head of Investor Relations +1 201 248 0741
jennifer.porcelli@centessa.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Oct 2023 to Oct 2024